HK1065029A1 - Cyclic diamine compound having five-membered cyclic group - Google Patents
Cyclic diamine compound having five-membered cyclic groupInfo
- Publication number
- HK1065029A1 HK1065029A1 HK04106463.1A HK04106463A HK1065029A1 HK 1065029 A1 HK1065029 A1 HK 1065029A1 HK 04106463 A HK04106463 A HK 04106463A HK 1065029 A1 HK1065029 A1 HK 1065029A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- alkyl
- atom
- aryl
- heteroaryl
- cyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Carbon And Carbon Compounds (AREA)
- Surface Treatment Of Glass Fibres Or Filaments (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/893,682 US6472386B1 (en) | 2001-06-29 | 2001-06-29 | Cyclic diamine compound with 5-membered ring groups |
PCT/JP2002/006488 WO2003002540A1 (en) | 2001-06-29 | 2002-06-27 | Cyclic diamine compound having five-membered cyclic group |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1065029A1 true HK1065029A1 (en) | 2005-02-08 |
Family
ID=25401912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04106463.1A HK1065029A1 (en) | 2001-06-29 | 2004-08-27 | Cyclic diamine compound having five-membered cyclic group |
Country Status (12)
Country | Link |
---|---|
US (1) | US6472386B1 (de) |
EP (1) | EP1400515B1 (de) |
JP (1) | JP4225895B2 (de) |
KR (1) | KR100878421B1 (de) |
CN (1) | CN100491355C (de) |
AT (1) | ATE464295T1 (de) |
CA (1) | CA2451238C (de) |
DE (1) | DE60235980D1 (de) |
ES (1) | ES2341945T3 (de) |
HK (1) | HK1065029A1 (de) |
TW (1) | TWI315307B (de) |
WO (1) | WO2003002540A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6632810B2 (en) * | 2001-06-29 | 2003-10-14 | Kowa Co., Ltd. | Cyclic diamine compound with condensed-ring groups |
US6395753B1 (en) * | 2001-08-30 | 2002-05-28 | Kowa Co., Ltd. | Cyclic amine compounds and pharmaceutical composition containing the same |
WO2005032490A2 (en) * | 2003-10-08 | 2005-04-14 | Bristol-Myers Squibb Company | Cyclic diamines and derivatives as factor xa inhibitors |
JP4634303B2 (ja) * | 2003-10-10 | 2011-02-16 | 興和株式会社 | 血管新生抑制薬 |
KR100893449B1 (ko) * | 2004-05-03 | 2009-04-17 | 에프. 호프만-라 로슈 아게 | 간-x-수용체 조절제로서의 인돌일 유도체 |
CN1953968B (zh) * | 2004-05-17 | 2012-10-10 | 大塚制药株式会社 | 噻唑化合物及其用途 |
WO2008045663A2 (en) * | 2006-10-06 | 2008-04-17 | Kalypsys, Inc. | Aryl-substituted heterocyclic pde4 inhibitors as antiinflammatory agents |
MX2010010135A (es) * | 2008-03-19 | 2010-10-25 | Bayer Cropscience Ag | Derivados de hidroximoil-tetrazol fungicidas. |
CN103562379A (zh) * | 2011-05-19 | 2014-02-05 | 国立大学法人德岛大学 | 细胞分化诱导剂以及分化诱导方法 |
US9181205B2 (en) | 2012-08-30 | 2015-11-10 | Otsuka Pharmaceutical Co., Ltd. | Method for producing oxazole compound |
US10189864B2 (en) | 2016-02-19 | 2019-01-29 | Lawrence Livermore National Security, Llc | Metal complexes based on a bis(2-pyridylmethyl)amine-based scaffold and methods of making the same |
US10112912B2 (en) * | 2016-03-02 | 2018-10-30 | Lawrence Livermore National Security, Llc | Homopiperazine-based catalysts for neutralization of organophosphorus-based compounds |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3808921B2 (ja) | 1995-11-20 | 2006-08-16 | 興和株式会社 | 細胞接着阻害剤 |
JP2000509070A (ja) | 1996-04-30 | 2000-07-18 | ヘキスト・マリオン・ルセル・インコーポレイテツド | 2,6―ジアルキル―4―シリル―フェノールを使用して血管細胞接着分子―1を阻害する方法および慢性炎症性疾患を治療する方法 |
JP3577183B2 (ja) | 1996-06-17 | 2004-10-13 | 花王株式会社 | 動脈硬化症予防・治療剤 |
JPH10147568A (ja) | 1996-11-19 | 1998-06-02 | Mitsui Chem Inc | ナフタレン誘導体およびそれを有効成分として含有する医薬品 |
JPH10182550A (ja) | 1996-12-25 | 1998-07-07 | Mitsui Chem Inc | ヒドロキシ安息香酸誘導体およびそれを有効成分として含有する医薬品 |
JP4139453B2 (ja) | 1997-09-24 | 2008-08-27 | 興和株式会社 | 細胞接着阻害剤 |
JP2000086641A (ja) | 1998-09-11 | 2000-03-28 | Kyorin Pharmaceut Co Ltd | 2−置換ベンゾチアゾール誘導体及びその製造法 |
JP2000319277A (ja) | 1999-05-11 | 2000-11-21 | Ono Pharmaceut Co Ltd | 縮合ピラジン化合物およびその化合物を有効成分とする薬剤 |
-
2001
- 2001-06-29 US US09/893,682 patent/US6472386B1/en not_active Expired - Fee Related
-
2002
- 2002-06-27 ES ES02736187T patent/ES2341945T3/es not_active Expired - Lifetime
- 2002-06-27 JP JP2003508921A patent/JP4225895B2/ja not_active Expired - Fee Related
- 2002-06-27 AT AT02736187T patent/ATE464295T1/de not_active IP Right Cessation
- 2002-06-27 WO PCT/JP2002/006488 patent/WO2003002540A1/ja active Application Filing
- 2002-06-27 CN CNB02813110XA patent/CN100491355C/zh not_active Expired - Fee Related
- 2002-06-27 EP EP02736187A patent/EP1400515B1/de not_active Expired - Lifetime
- 2002-06-27 DE DE60235980T patent/DE60235980D1/de not_active Expired - Lifetime
- 2002-06-27 KR KR1020037016479A patent/KR100878421B1/ko not_active IP Right Cessation
- 2002-06-27 CA CA2451238A patent/CA2451238C/en not_active Expired - Fee Related
- 2002-06-28 TW TW091114323A patent/TWI315307B/zh not_active IP Right Cessation
-
2004
- 2004-08-27 HK HK04106463.1A patent/HK1065029A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2451238A1 (en) | 2003-01-09 |
KR100878421B1 (ko) | 2009-01-13 |
WO2003002540A1 (en) | 2003-01-09 |
EP1400515B1 (de) | 2010-04-14 |
CN1522250A (zh) | 2004-08-18 |
EP1400515A1 (de) | 2004-03-24 |
KR20040015737A (ko) | 2004-02-19 |
ATE464295T1 (de) | 2010-04-15 |
US6472386B1 (en) | 2002-10-29 |
JPWO2003002540A1 (ja) | 2004-10-14 |
CN100491355C (zh) | 2009-05-27 |
TWI315307B (de) | 2009-10-01 |
EP1400515A4 (de) | 2004-11-24 |
CA2451238C (en) | 2011-01-04 |
ES2341945T3 (es) | 2010-06-30 |
JP4225895B2 (ja) | 2009-02-18 |
DE60235980D1 (de) | 2010-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1065029A1 (en) | Cyclic diamine compound having five-membered cyclic group | |
MY142807A (en) | Benzimidazole derivative and use thereof. | |
EP1852434A4 (de) | Bicyclisches carbamoylpyridonderivat mit hiv-integrase-hemmender wirkung | |
HK1119707A1 (en) | Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders | |
ATE383340T1 (de) | Unsymmetrische zyklische diaminverbindung | |
DK1533292T3 (da) | Dibenzylaminforbindelse og medicinsk anvendelse deraf | |
MXPA04009497A (es) | Piridinoilpiperidinas como antagonistas de 5-ht1f. | |
PT1052254E (pt) | Derivados heterocíclicos azotados e medicamento dos mesmos | |
EP1277736A4 (de) | Neue bizyklische verbindungen | |
EP1217001A4 (de) | Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten | |
NZ514158A (en) | Derivatives of pyrimido[6,1-a]isoquinolin-4-one | |
DK1961734T3 (da) | Aminforbindelse og anvendelse deraf til medicinske formål | |
TW200635594A (en) | Phenyl-piperazin methanone derivatives | |
DK0790987T3 (da) | Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer | |
HK1065306A1 (en) | Cyclic diamine compounds having fused-ring groups | |
ATE272617T1 (de) | Sulfonamid-derivate | |
NO20020621L (no) | Antibakterielle midler | |
EP2100895A4 (de) | Tricyclische verbindung und deren medizinische verwendung | |
EP1375496A4 (de) | N-aryl-substituiertes cyclisches aminderivat und medizin, die dieses als wirkstoff enthält | |
HK1080472A1 (en) | Process for the preparation of amino-pyrrolidine derivatives | |
DE69523259D1 (de) | Amine Derivate, ihre Herstellung und Anwendung | |
DK1899331T3 (da) | Homomorpholinoxazolidnoner som antibakterielle midler | |
HK1130496A1 (en) | 3'-ethynylcytidine derivative 3'- | |
HK1065031A1 (en) | Cyclic diamine compounds bearing six-membered cyclic groups | |
TWI367097B (de) |